A general heuristic for interpreting condition trends: triangulate diagnoses/incidence with disability burden and mortality to avoid misreads from screening changes, coding incentives, or shock-driven detection gaps.
— Prevents policy and media errors across health (and beyond) by prioritizing harm-centric outcomes over volatile detection metrics, improving resource allocation and public trust.
Scott Alexander
2025.08.14
60% relevant
The article highlights why cross‑sectional amyloid–symptom correlations mislead given long lead times and mediators (tau, neurodegeneration), exemplifying the need to triangulate upstream biomarkers with downstream functional outcomes to avoid metric-driven misinterpretation.
Saloni Dattani
2025.06.16
90% relevant
The article argues explicitly that harms shouldn’t be judged by deaths alone; measles-induced immune ‘amnesia’ causes prolonged morbidity and complications, so proper burden assessment must triangulate beyond incidence and mortality to long-run functional harms and hospitalizations.
Cremieux
2025.06.05
100% relevant
The post argues that COVID-era diagnosis declines didn’t reflect incidence and shows youth cancer DALYs fell 1990–2019, urging evaluation beyond diagnoses alone.